Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF)
Age- and Gender-Related Differences in Quality of Care and Outcomes of Patients Hospitalized With Heart Failure (from OPTIMIZE-HF)
复制标题
DOI：
10.1016/j.amjcard.2009.02.057
复制
发表时间：
2009-07-01
影响因子：
2.8
通讯作者：
Young, James B.
中科院分区：
文献类型：
--
作者：
Fonarow, Gregg C.;Abraham, William T.;Young, James B.
先前的研究表明，患有心力衰竭（HF）的女性和老年患者不太可能接受指南推荐的治疗，但这些研究涉及了特定的患者群体。我们评估了一大群住院心力衰竭患者中按年龄和性别划分的医疗护理和患者结果的差异。对住院心力衰竭患者启动挽救生命治疗的有组织计划 (OPTIMIZE-HF) 是一项登记和绩效改进计划，涉及来自 259 家医院的 48,612 名心力衰竭患者。数据按性别进行分析，年龄 = 75 岁。女性和男性适当使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂和 P 阻滞剂的情况相似（分别为 p = 0.244 和 p = 0.237）。然而，与男性相比，收到出院指示的女性较少（p
Previous studies have suggested that female and elderly patients with heart failure (HF) are less likely to receive guideline-recommended therapies, but these studies have involved select patient populations. We evaluated the differences in medical care and patient outcomes by age and gender among a broad cohort of hospitalized patients with HF. The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) is a registry and performance-improvement program involving 48,612 patients with HF from 259 hospitals. The data were analyzed by gender, age = 75 years. Appropriate angiotensin-converting enzyme inhibitor/angiotensin receptor blocker and P-blocker use were similar between women and men (p = 0.244 and p = 0.237, respectively). However, compared with men, fewer women received hospital discharge instructions (p